Oppenheimer analyst Kevin DeGeeter downgrades ORIC Pharmaceuticals (NASDAQ:ORIC) from Outperform to Perform.
Hycroft Mining CEO Says At Some Point, Co. Will Be Raising Money To Do Construction For A Mining Project But Says Co. Is Capitalized Well Into The Future
https://www.youtube.com/watch?v=ppvZVPj3Ao8